Glox Therapeutics
PrivateLast Round
Grant
Jan 21, 2025
Total Funding Raised
$7.24M
Company Overview
Glox Therapeutics is a biotechnology company developing a pipeline of engineered precision bacteriocins targeting pathogens that cause serious infections associated with high levels of antimicrobial resistance (AMR).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glox Therapeutics Comparables
Compare Glox Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DimiCare Biotech | 81% | |
| SNIPR Biome | 79% | |
| PrecisioBiotix Therapeutics | 77% |
Glox Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 21, 2025 | ||||
| Grant | Nov 20, 2024 | ||||
| Seed | Nov 14, 2023 |
Key People
Founding team and executive leadership
Glox Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| LifeArc | Grant |
| Boehringer Ingelheim Venture Fund | Seed |
| Scottish Investment Bank (Scottish Enterprise) | Seed |
| CF AMR Syndicate | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2025
Grew 63% QoQ, from 8 to 13 employees.
- Jun 6, 2025
Grew 50% QoQ, from 8 to 12 employees.
Glox Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Glox Therapeutics's valuation, stock price, and market status.
Is Glox Therapeutics a public or private company?
Glox Therapeutics is a private company.
What is the current stock price of Glox Therapeutics?
Glox Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Glox Therapeutics worth (valuation)?
Valuation information for Glox Therapeutics is not publicly available.
Can I buy Glox Therapeutics stock?
Glox Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Glox Therapeutics's last funding round?
Funding round information for Glox Therapeutics is not publicly available.
Who are the main investors in Glox Therapeutics?
Investor information for Glox Therapeutics is not publicly disclosed.
Will Glox Therapeutics IPO soon?
No public IPO plans have been announced for Glox Therapeutics.
How can I track Glox Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Glox Therapeutics's secondary market activity and sign up for updates.